Filing Flows

Filing Flows › Industries › Health Care › Services-Offices & Clinics of Doctors of Medicine

Services-Offices & Clinics of Doctors of Medicine SIC 8011

8 companies filing with the SEC under SIC 8011. Median revenue growth -3% year on year in Q2 2026 (middle half -23% to +19%, 8 companies). The growth model expects the industry's combined revenue to grow +18% in Q3 2026. 2 customer or supplier links named in annual reports.

Companies8
Median growth Y/Y-3%
Middle half-23% to +19%
Industry revenue, next quarter+18% Y/Y (Q3 2026, model)
Services-Offices & Clinics of Doctors of Medicine: the largest companies by quarterly revenueServices-Offices & Clinics of Doctors of Medicine: the largest companies by quarterly revenueHIMS$753MTDOC$605MSTLN$170MSBC$49.2MLFMD$47.3MAIRS$31.9MCDIX$2.2MHLYK$250K
Services-Offices & Clinics of Doctors of Medicine: how many companies grew how fast (revenue, year over year)Services-Offices & Clinics of Doctors of Medicine: how many companies grew how fast (revenue, year over year)1< −25%2−25 to −10%2−10 to 0%00 to 10%110 to 25%225 to 50%0> 50%
Services-Offices & Clinics of Doctors of Medicine: the growth model's forecast of industry revenueServices-Offices & Clinics of Doctors of Medicine: the growth model's forecast of industry revenue80% rangemodel's central forecastQ3 2026$1.8BQ4 2026$1.8BQ1 2027$1.9BQ2 2027$2.1B

Money flow: where the industry's revenue goes

Drawn in the browser: an estimate of where the industry's revenue goes — what it buys from other industries, the pay that reaches households, taxes and profit — beside its filed cash flow, two tiers of suppliers and its capital spending by kind of asset.

Open the industry: growth distribution, money flow, network →

Who sells to whom

Customers and suppliers named in the companies' annual reports; the share is of the supplier's revenue.

Growth model

Industry revenue, the same companies year on year; 80% ranges. Fitted on SEC filings and tested out of sample (how).

QuarterGrowth Y/YRevenue80% range
Q3 2026+18.5%$1.8B$1.3B – $2.3B
Q4 2026+21.4%$1.8B$1.2B – $2.4B
Q1 2027+23.5%$1.9B$1.1B – $2.6B
Q2 2027+25.0%$2.1B$1.2B – $2.9B

Capital spending and supply chain →

Companies

CompanyQuarterly revenueY/YStage
HIMS Hims & Hers Health$753M+38%expansion
TDOC Teladoc Health$605M-4%mature
STLN Starling Oncology$170M+35%deceleration
SBC SBC Medical Group Holdings$49.2M+13%reacceleration
LFMD LifeMD$47.3M-24%contraction
AIRS Airsculpt Technologies$31.9M-3%mature
CDIX Cardiff Lexington$2.2M-23%transition
HLYK HealthLynked$250K-58%contraction

Growth from positive, comparable quarterly revenue as filed; industries are SEC Standard Industrial Classification codes. Data Nov 8, 2026.